期刊文献+

真武汤对心力衰竭大鼠血清ST2及IL-33影响 被引量:11

Effect of Zhenwu Decoction on ST2 and IL-33 in Heart Failure Rats
原文传递
导出
摘要 目的:观察真武汤对心力衰竭大鼠血清ST2及IL-33的影响,并探讨其作用机制。方法:以80只健康雄性Wistar大鼠为研究对象,除空白组10只外,其余70只通过冠脉结扎手术,术后结合冷水力竭式游泳,复制心力衰竭动物模型,把造模后存活的50只大鼠随机分为真武汤高剂量组、中剂量组、低剂量组、西药组和模型组5组,分别予以真武汤、卡托普利、生理盐水灌胃,疗程15 d。用酶联免疫吸附试验法(ELISA)测定大鼠血浆ST2、白细胞介素-33(IL-33)水平。结果:中药高剂量组、西药组FS值与EF值与模型组比较显著升高(P<0.01),中药高剂量组、西药组大鼠FS值、EF值与正常组比较差异无统计学意义(P>0.05);模型组ST2、IL-33水平均显著升高(P<0.01),中药高剂量组、中剂量组与西药组ST2、IL-33水平显著降低(P<0.01),西药组与中药高剂量组、中剂量组比较差异无统计学意义(P>0.05),中药高剂量组、中剂量组IL-33水平较正常组无统计学意义(P>0.05)。结论:真武汤能够明显降低心力衰竭大鼠血清ST2、IL-33水平,说明真武汤通过调控IL-33/ST2L信号通路改善心室重构,这可能是真武汤治疗心力衰竭的机制之一。 Objective:To observe the effect of Zhenwu Decoction on serum ST2 and IL-33 in heart failure rats,and to explore its mechanism of action. Methods:In 80 healthy male Wistar rats as the research object,except the blank group(10 rats),the remaining 70 only by ligation of coronary artery,postoperative combined with cold water swimming exhaustion,replication of animal model of heart failure,modeled after the survival of 50 rats were randomly divided into two groups:Zhenwu Decoction high dose group,middle dose group,low dose group,western medicine group and model group 5 group,and were treated with Zhenwu Decoction and captopril,saline gavage treatment course was 15 days. ST2 and IL-33 levels were measured by enzyme-linked immunosorbent assay(ELISA)method. Results:Traditional Chinese medicine high dose group,western medicine group,FS and EF values and model groups increased significantly(P〈0.01),traditional Chinese medicine high dose group,western medicine group rats FS,EF value and normal group had no statistical significance(P〉0.05);model group ST2,IL-33 levels were significantly increased(P〈0.01),traditional Chinese medicine high dose group,middle dose group and Western medicine group ST2,IL-33 levels decreased significantly(P〈0.01),western medicine group and traditional Chinese medicine high dose group,middle dose group,the difference was not statistically significant(P〉0.05),traditional Chinese medicine high dose group,middle dose group of IL-33 levels compared with the normal group had no statistical significance(P〉0.05). Conclusion:Zhenwu Decoction can significantly reduced heart failure rat serum ST2,IL-33 levels,that Zhenwu Decoction by regulation IL-33/ST2 L signaling pathway improve ventricular reconstruction,which may is one of the mechanisms of Zhenwu Decoction in the treatment of heart failure.
出处 《辽宁中医药大学学报》 CAS 2016年第5期25-27,共3页 Journal of Liaoning University of Traditional Chinese Medicine
基金 国家自然科学基金面上项目(81173184)
关键词 心衰 真武汤 大鼠 heart failure Zhenwu Decoction rat
  • 相关文献

参考文献15

  • 1Damien G,Thibauh L,Sylvie AA,et al.Increased soluble ST2is a stronger predictor of long-term cardiovascular death than natriuretie peptides in heart failure patients with reduced ejection raction[J].Int J Cardiol,2014,172(1):250-252.
  • 2徐淑云.药理实验设计中的剂量问题[M]//高华.药理试验方法学.北京:人民卫生出版社,2002.
  • 3Rehman S U,Mueller T,Januzzi J L Jr.Characteristics of the novelinterleukin family biomarker ST2 in patients with acute heart failure[J].J Am Coll Cardiol,2008,52:1458-1465.
  • 4Seki K,Sanada S,Kudinova AY,et al.Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling[J].Circ Heart Fail,2009,2:684-691.
  • 5Cieeone MM,Cortese F,Gesualdo M,et al.A novel cardiac biomarker ST2:a review[J].Molecules,2013,18(12):15314-15328.
  • 6Bartunek J,Delrue L,Van Durme F,et al.Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load[J].J Am Coll Cardiol,2008,52:2166-2174.
  • 7Schmitz J,Owyang A,Oldham E,et al.IL-33,an interleukin-1-like cytokine that signals via the IL-1 receptor-relatedprotein ST2and induces T helper type 2-associated cytokines[J].Immunity,2005;3(5):479-490.
  • 8Sanada S,Hakuno D,Higgins LJ,et al.IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system[J].J Clin Invest,2007,117:1538-1549.
  • 9Saenz SA,Taylor BC,Artis D.Welcome to the neighborhood:e andadaptiveimmune responses at mucosal sites[J].Immunol Rev,2008,226:172-190.
  • 10Ali S,Huber M,Kollewe C,et al.IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells[J].Proc Natl Acad Sci USA,2007,104:18660-18665.

二级参考文献20

  • 1全国心力衰竭诊断与治疗专题研讨会纪要[J].中华心血管病杂志,1995,23(2):95-100. 被引量:54
  • 2解丽艳,王晏平,范茜,刘萍,董海.老年人心力衰竭与C-反应蛋白肾上腺髓质素脑钠素和基质金属蛋白酶的关系[J].中华老年医学杂志,2005,24(9):655-658. 被引量:9
  • 3卜法芹.AMI患者血浆脑钠肽水平测定及其与左室重构的关系[J].山东医药,2007,47(2):45-46. 被引量:12
  • 4美国心脏病学会/美国心脏病协会工作组.美国成人慢性心力衰竭诊断与治疗指南[S].颜红兵,译.北京:中国环境科学出版社,2005:79285.
  • 5李伟 刘克强.心力衰竭患者生命质量的影响因素与对策研究进展[J].中国慢性病预防与控制,2010,7(1):70-72.
  • 6中华人民共和国卫生部制定发布.中药新药临床研究指导原则[S].,1993.215—218.
  • 7赵金铎.中医症状鉴别诊断学[M].北京:人民卫生出版社,1984.97.
  • 8Mc Cullough PA, Nowak RM, Mc Cord J, et al .B - typeM a tri- ure tic Peptide and C linical Judgment i n Em ergencyD iagnosis of H eart Failure : Ana 1 y si s from B tea t h i ng Notproper 1 y ( BNP ), Multi nati ona 1 Study [ J ] . Circulation,2002, 106 ( 4): 419-422.
  • 9Hunt SA,Baker DW, C hin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the a- dult[ J ]. J Am CardioI,2001,38 :2101 - 2113.
  • 10朱文锋.中医诊断学[M].上海,上海科学技术出版社,2008:142-166.

共引文献115

同被引文献164

引证文献11

二级引证文献117

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部